Editas Medicine (EDIT) Non-Current Deffered Revenue (2015 - 2025)
Editas Medicine (EDIT) posted Non-Current Deffered Revenue of $44.51 million for Q4 2025, down 17.9% from $54.2 million a year earlier and down 17.9% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Non-Current Deffered Revenue (2015 - 2025) Analysis & Trends
Since Q4 2015, Editas Medicine has reported Non-Current Deffered Revenue for 41 quarters.
- Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of -9.7% (FY2020 to FY2025).
- In prior years, Editas Medicine's Non-Current Deffered Revenue was $54.2 million in FY2024 (-10.7%), $60.67 million in FY2023 (unchanged), $60.67 million in FY2022 (-0.4%) and $60.89 million in FY2021 (-17.7%).
- The Q4 2025 figure stands as the lowest quarterly Non-Current Deffered Revenue since Q4 2016.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q2 2022, with growth of 24.7%; the weakest was Q2 2021, with a decline of 60.1%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $54.2 million (Q3 2025), $54.2 million (Q2 2025) and $54.2 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | - |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Editas Medicine | 232.23 Mn | -479.53 Mn | - | 44.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 44.51 Mn |
| Sep 30, 2025 | 54.20 Mn |
| Jun 30, 2025 | 54.20 Mn |
| Mar 31, 2025 | 54.20 Mn |
| Dec 31, 2024 | 54.20 Mn |
| Sep 30, 2024 | 54.20 Mn |
| Jun 30, 2024 | 54.20 Mn |
| Mar 31, 2024 | 54.20 Mn |
| Dec 31, 2023 | 60.67 Mn |
| Sep 30, 2023 | 60.67 Mn |
| Jun 30, 2023 | 60.67 Mn |
| Mar 31, 2023 | 60.67 Mn |
| Dec 31, 2022 | 60.67 Mn |
| Sep 30, 2022 | 64.67 Mn |
| Jun 30, 2022 | 68.89 Mn |
| Mar 31, 2022 | 60.89 Mn |
| Dec 31, 2021 | 60.89 Mn |
| Sep 30, 2021 | 60.89 Mn |
| Jun 30, 2021 | 55.22 Mn |
| Mar 31, 2021 | 56.67 Mn |
API Access
Editas Medicine Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();